Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2602750> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- Q2602750 subject Q6372407.
- Q2602750 subject Q7215001.
- Q2602750 subject Q8301176.
- Q2602750 subject Q9052323.
- Q2602750 abstract "Diflunisal is a salicylic acid derivative with analgesic and anti-inflammatory activity. It was developed by Merck Sharp & Dohme in 1971 after showing promise in a research project studying more potent chemical analogs of aspirin. It was first sold under the brand name Dolobid, marketed by Merck & Co., but generic versions are now widely available. It is classed as a non-steroidal anti-inflammatory drug (NSAID) and is available in 250 mg and 500 mg tablets.".
- Q2602750 atcPrefix "N02".
- Q2602750 atcSuffix "BA11".
- Q2602750 bioavailability "80.0".
- Q2602750 casNumber "22494-42-4".
- Q2602750 chEBI "39669".
- Q2602750 drugbank "DB00861".
- Q2602750 fdaUniiCode "7C546U4DEN".
- Q2602750 iupacName "2',4'-difluoro-4-hydroxybiphenyl-3-carboxylic acid".
- Q2602750 pubchem "3059".
- Q2602750 thumbnail Diflunisal_structure.svg?width=300.
- Q2602750 wikiPageExternalLink dolobid_mg.pdf.
- Q2602750 wikiPageExternalLink dolobid_pi.pdf.
- Q2602750 wikiPageExternalLink a684037.html.
- Q2602750 wikiPageExternalLink ab007440.html.
- Q2602750 wikiPageWikiLink Q170990.
- Q2602750 wikiPageWikiLink Q173235.
- Q2602750 wikiPageWikiLink Q18216.
- Q2602750 wikiPageWikiLink Q188724.
- Q2602750 wikiPageWikiLink Q193572.
- Q2602750 wikiPageWikiLink Q202517.
- Q2602750 wikiPageWikiLink Q209583.
- Q2602750 wikiPageWikiLink Q209717.
- Q2602750 wikiPageWikiLink Q247489.
- Q2602750 wikiPageWikiLink Q2844603.
- Q2602750 wikiPageWikiLink Q288280.
- Q2602750 wikiPageWikiLink Q582687.
- Q2602750 wikiPageWikiLink Q6372407.
- Q2602750 wikiPageWikiLink Q7215001.
- Q2602750 wikiPageWikiLink Q8301176.
- Q2602750 wikiPageWikiLink Q9052323.
- Q2602750 wikiPageWikiLink Q9368.
- Q2602750 wikiPageWikiLink Q9377.
- Q2602750 atcPrefix "N02".
- Q2602750 atcSuffix "BA11".
- Q2602750 bioavailability "80".
- Q2602750 casNumber "22494".
- Q2602750 chebi "39669".
- Q2602750 drugbank "DB00861".
- Q2602750 iupacName "120.0".
- Q2602750 pubchem "3059".
- Q2602750 unii "7".
- Q2602750 type ChemicalSubstance.
- Q2602750 type Drug.
- Q2602750 type ChemicalObject.
- Q2602750 type Thing.
- Q2602750 type Q8386.
- Q2602750 comment "Diflunisal is a salicylic acid derivative with analgesic and anti-inflammatory activity. It was developed by Merck Sharp & Dohme in 1971 after showing promise in a research project studying more potent chemical analogs of aspirin. It was first sold under the brand name Dolobid, marketed by Merck & Co., but generic versions are now widely available. It is classed as a non-steroidal anti-inflammatory drug (NSAID) and is available in 250 mg and 500 mg tablets.".
- Q2602750 label "Diflunisal".
- Q2602750 depiction Diflunisal_structure.svg.